Cantel Medical (NYSE: CMN) reported Q3 EPS of $0.35, $0.06 better than the analyst estimate of $0.29. Revenue for the quarter came in at $120.06 million versus the consensus estimate of $135.95 million.

For earnings history and earnings-related data on Cantel Medical (CMN) click here.